Lifecore Biomedical, Inc. LFCR Business Segments
| Q4 '26 | Q2 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| CDMO | $15.78M-27.5% | $21.75M-7.5% | $23.52M+13.1% | $20.79M-18.8% | $25.61M+26.9% | |
| HA manufacturing | $7.42M-20.7% | $9.36M-27.6% | $12.93M-10.0% | $14.37M+107% | $6.95M+53.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Lifecore Biomedical, Inc. break its business down?
- Lifecore Biomedical, Inc. (LFCR) reports revenue by product across 2 parts — CDMO and HA manufacturing. Each is extracted from the segment footnotes and tracked over time.
- Where does Lifecore Biomedical, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Lifecore Biomedical, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
